1. Buyer
1.1.
Buyer
Official name: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Legal type of the buyer: Regional authority
Activity of the contracting authority: General public services
2. Procedure
2.1.
Procedure
Title: Suministro de los principios activos denominados "Faricimab 28,8 MG / 0,24 ML VIAL 0,24 ML Intravitrea" Y "Polatuzumab Vedotina 30MG POLVO PERFUSION".
Description: Dicho objeto corresponde al código 33690000-3 Medicamentos diversos, de la nomenclatura Vocabulario Común de Contratos (CPV) de la Comisión Europea.
Procedure identifier: cb88e792-0a83-49b3-b4aa-ddbe169a04bd
Internal identifier: SUM/2024/0000060239
Type of procedure: Negotiated without prior call for competition
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33690000 Various medicinal products
2.1.2.
Place of performance
Country subdivision (NUTS): Gran Canaria (ES705)
Country: Spain
2.1.4.
General information
Legal basis:
Directive 2014/24/EU
5. Lot
5.1.
Lot: LOT-0001
Title: Faricimab 28,8 mg / 0,24 ml vial 0,24 ml INTRAVITR
Description: Faricimab 28,8 mg / 0,24 ml vial 0,24 ml INTRAVITR
Internal identifier: 1
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33690000 Various medicinal products
5.1.2.
Place of performance
Country subdivision (NUTS): El Hierro (ES703)
Country: Spain
Anywhere in the given country
5.1.2.
Place of performance
Country subdivision (NUTS): Fuerteventura (ES704)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): Gran Canaria (ES705)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): La Gomera (ES706)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): La Palma (ES707)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): Lanzarote (ES708)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): Tenerife (ES709)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 201 352,50 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.7.
Strategic procurement
Aim of strategic procurement: No strategic procurement
5.1.10.
Award criteria
Criterion:
Type: Price
Description: Precio.
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín - Tribunal Administrativo de Contratación Pública de la Comunidad Autónoma de Canarias
5.1.
Lot: LOT-0002
Title: Polatuzumab Vedotina 30 mg polvo perfusion
Description: Polatuzumab Vedotina 30 mg polvo perfusion
Internal identifier: 2
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33690000 Various medicinal products
5.1.2.
Place of performance
Country subdivision (NUTS): El Hierro (ES703)
Country: Spain
Anywhere in the given country
5.1.2.
Place of performance
Country subdivision (NUTS): Fuerteventura (ES704)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): Gran Canaria (ES705)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): La Gomera (ES706)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): La Palma (ES707)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): Lanzarote (ES708)
Country: Spain
5.1.2.
Place of performance
Country subdivision (NUTS): Tenerife (ES709)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 286 353,60 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.7.
Strategic procurement
Aim of strategic procurement: No strategic procurement
5.1.10.
Award criteria
Criterion:
Type: Price
Description: Precio.
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín - Tribunal Administrativo de Contratación Pública de la Comunidad Autónoma de Canarias
6. Results
Value of all contracts awarded in this notice: 487 706,10 EUR
Direct award:
Justification for direct award: The contract can be provided only by a particular economic operator because of an absence of competition for technical reasons
Other justification: negociado sin publicidad
6.1.
Result lot identifier: LOT-0001
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner:
Official name: Roche Farma, S.A.
Tender:
Tender identifier: REF TEN-0001/LOT-0001
Identifier of lot or group of lots: LOT-0001
Value of the tender: 201 352,50 EUR
The tender was ranked: no
Contract information:
Identifier of the contract: CONT/2025/0000000037
Date on which the winner was chosen: 22/01/2025
Date of the conclusion of the contract: 25/02/2025
The contract is awarded within a framework agreement: no
6.1.4.
Statistical information
Received tenders or requests to participate:
Type of received submissions: Tenders from micro, small or medium tenderers
Number of tenders or requests to participate received: 0
Type of received submissions: Tenders
Number of tenders or requests to participate received: 1
Range of tenders:
Value of the lowest admissible tender: 201 352,50 EUR
Value of the highest admissible tender: 201 352,50 EUR
6.1.
Result lot identifier: LOT-0002
Winner selection status: At least one winner was chosen.
6.1.4.
Statistical information
Received tenders or requests to participate:
Type of received submissions: Tenders from micro, small or medium tenderers
Number of tenders or requests to participate received: 0
Type of received submissions: Tenders
Number of tenders or requests to participate received: 1
Range of tenders:
Value of the lowest admissible tender: 286 353,60 EUR
Value of the highest admissible tender: 286 353,60 EUR
8. Organisations
8.1.
ORG-0001
Official name: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Registration number: 21050930148853
Registration number: Q8555011I
Town: Las Palmas de Gran Canaria
Postcode: 35019
Country: Spain
Contact point: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Telephone: +034 928450147
Fax: +034 928449814
Other contact points:
Official name: Tribunal Administrativo de Contratación Pública de la Comunidad Autónoma de Canarias
Town: Las Palmas de Gran Canaria
Postcode: 35007
Country: Spain
Telephone: +034 928578124
Fax: +034 928578127
Roles of this organisation:
Buyer
Review organisation
8.1.
ORG-0002
Official name: Roche Farma, S.A.
Size of the economic operator: Large
Registration number: A08023145
Town: Madrid
Postcode: 28042
Country: Spain
Telephone: +34 913248100
Roles of this organisation:
Tenderer
Beneficial owner:
Nationality of the owner: Spain
Winner of these lots: LOT-0001
8.1.
ORG-0003
Official name: Roche Farma, S.A.
Size of the economic operator: Large
Registration number: A08023145
Town: Madrid
Postcode: 28042
Country: Spain
Telephone: +34 913248100
Roles of this organisation:
Tenderer
Beneficial owner:
Nationality of the owner: Spain
Notice identifier/version: 6dd734a8-cdc8-48a5-922a-0e44a5f4fa57 - 01
Form type: Result
Notice type: Contract or concession award notice – standard regime
Notice subtype: 29
Notice dispatch date: 07/03/2025 11:20:37 (UTC+01:00) Central European Time, Western European Summer Time
Languages in which this notice is officially available: Spanish
Notice publication number: 154172-2025
OJ S issue number: 48/2025
Publication date: 10/03/2025